GOSS
Gossamer Bio Inc
10.90$
+0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Gossamer Bio Inc (GOSS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -39 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -34 | -33 | -52 | 116 | -32 | -35 | -40 | -47 | -36 | -48 | -39 | -39 | -163 | |
| 1.1 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.7 | |
| 6.2 | 6.0 | 5.8 | 5.0 | 4.8 | 5.0 | 2.4 | 2.6 | 2.7 | 2.9 | 6.3 | 2.5 | 14 | |
| 0.1 | 1.0 | -15 | 64 | -4.1 | -5.6 | -3.4 | -9.9 | 3.0 | -3.4 | 1.8 | -7.9 | -6.4 | |
| 0.0 | 0.1 | 0.0 | 116 | 32 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -118 | -14 | 62 | -59 | -27 | 53 | 22 | 44 | 17 | 73 | 42 | 43 | 174 | |
| – | 0.1 | 0.3 | – | 0.3 | – | 0.4 | – | 0.5 | – | 0.3 | – | – | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| 198 | -2.9 | -2.6 | -9.2 | 0.3 | 0.0 | 0.5 | 0.1 | 1.9 | 4.0 | 0.5 | -3.1 | 3.2 | |
| 46 | -51 | 6.8 | 48 | -58 | 18 | -17 | -2.7 | -17 | 29 | 3.3 | 0.1 | 15 | |
| -34 | -33 | -52 | 116 | -32 | -35 | -40 | -47 | -36 | -48 | -39 | -39 | -163 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.